Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: Evidence for a specific tissue-type plasminogen activator receptor on these cells

Blood

Volumn 90, Issue 6, 1997, Pages 2312-2322

  Ellis, Vincent ^a   Whawell, Simon A ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; PLASMIN; PLASMINOGEN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BINDING AFFINITY; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LIGAND BINDING; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0030807309     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2312.2312_2312_2322     Document Type: Article

References (55)

1. Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 314:488, 1986
2. McBride W, Lange RA, Hillis LD: Restenosis after succesful coronary angioplasty. N Engl J Med 318:1734, 1988
3. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493, 1994
4. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seiffert D, Thinnes T, Bernstein EF, Dilley RB, Loskutoft DJ: Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest 96:639, 1995
5. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D: Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 67:61, 1990
6. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 15:1444, 1995
7. Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES: Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 15:1432, 1995
8. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181, 1994
9. Bendeck MP, Irvin C, Reidy MA: Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78:38, 1996
10. Murphy G, Willenbrock F, Crabbe T, O'Shea M, Ward R, Atkinson S, O'Connell J, Docherty A: Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 732:31, 1994
11. Sato Y, Rifkin DB: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin. J Cell Biol 109:309, 1989
12. Saksela O, Rifkin DB: Release of basic fibroblast growth factor-heparan sulphate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 110:767, 1990
13. Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88:3739, 1991
14. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC: Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature 370:460, 1994
15. Carmeliet P, Collen D: Gene targeting and gene transfer studies of the plasminogen/plasmin system: Implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. [Review] FASEB J 9:934, 1995
16. Jackson CL, Raines EW, Ross R, Reidy MA: Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 13:1218, 1993
17. Clowes AW, Clowes MM, Kirkman TR, Jackson CL, Au YP, Kenagy R: Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res 70:1128, 1992
18. Ellis V, Scully MF, Kakkar VV: Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264:2185, 1989
19. Ellis V, Pyke C, Eriksen J, Solberg H, Danø K: The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci 667:13, 1992
20. Ellis V, Behrendt N, Danø K: Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem 266:12752, 1991
21. Grobmyer SR, Kuo A, Orishimo M, Okada SS, Cines DB, Barnathan ES: Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells. J Biol Chem 268:13291, 1993
22. Reuning U, Little SP, Dixon EP, Bang NU: Effect of thrombin, the thrombin receptor activation peptide, and other mitogens on vascular smooth muscle cell urokinase receptor mRNA levels. Blood 84:3700, 1994
23. Rønne E, Behrendt N, Ellis V, Ploug M, Danø K, Høyer-Hansen G: Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor. FEBS Lett 288:233, 1991
24. Ellis V, Danø K: Potentiation of plasmmogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation. J Biol Chem 268:4806, 1993
25. Benzakour O, Kanthou C, Kanse SM, Scully MF, Kakkar VV, Cooper DN: Evidence for cultured human vascular smooth muscle cell heterogeneity: Isolation of clonal cells and study of their growth characteristics. Thromb Haemost 75:854, 1996
26. Lund LR, Ellis V, Rønne E, Pyke C, Danø K: Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem J 310:345, 1995
27. Ellis V, Behrendt N, Danø K: Cellular receptor for urokinase-type plasminogen activator: Function in cell-surface proteolysis. Methods Enzymol 223:223, 1993
28. Blasi F: Surface receptors for urokinase plasminogen activator. Fibrinolysis 2:73, 1988
29. Otter M, Barrett-Bergshoeff MM, Rijken DC: Binding of tissue-type plasminogen activator by the mannose receptor. J Biol Chem 266:13931, 1991
30. Plesner T, Ploug M, Ellis V, Rønne E, Høyer-Hansen G, Wittrup M, Pedersen TL, Tscherning T, Danø K, Hansen NE: The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83:808, 1994
31. Bugge TH, Suh TT, Flick MJ, Daugherty CC, Rømer J, Solberg H, Ellis V, Danø K, Degen JL: The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 270:16886, 1995
32. Stack MS, Rinehart AR, Pizzo SV: Comparison of plasminogen binding and activation on extracellular matrices produced by vascular smooth muscle and endothelial cells. Eur J Biochem 226:937, 1994
33. Okada SS, Tomaszewski JE, Barnathan ES: Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp Cell Res 217:180, 1995
34. Stahl A, Mueller BM: The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 129:335, 1995
35. Rothberg KG, Ying Y-S, Kamen BA, Anderson RGW: Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 111:2931, 1990
36. Smart EJ, Foster DC, Ying Y-S, Kamen BA, Anderson RGW: Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae. J Cell Biol 124:307, 1994
37. Solberg H, Løber D, Eriksen J, Ploug M, Rønne E, Behrendt N, Danø K, Høyer-Hansen G: Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Eur J Biochem 205:451, 1992
38. 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J Biol Chem 268:21862, 1993
39. Pirie-Shepherd SR, Blasco E, Pizzo SV: Heparin as an hyperbolic modulator of plasminogen activation by t-PA. Fibrinolysis 8:182, 1994
40. Ramakrishnan V, Sinicropi DV, Dere R, Darbonne WC, Bechtol KB, Baker JB: Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers. J Biol Chem 265:2755, 1990
41. Hajjar KA, Hamel NM, Harpel PC, Nachman RL: Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 80:1712, 1987
42. Barnathan ES, Kuo A, Van der Keyl H, McRae KR, Larsen GR, Cines DB: Tissue plasminogen activator binding to endothelial cells. Evidence for two distinct binding sites. J Biol Chem 263:7792, 1988
43. Russell ME, Quertermous T, Declerck PJ, Collen D, Haber E, Homcy CJ: Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1. J Biol Chem 265:2569, 1990
44. Kuiper J, Van't Hof A, Otter M, Biessen EAL, Rijken DC, Van Berkel TJC: Interaction of mutants of tissue-type plasminogen activator with liver cells: Effect of domain deletions. Biochem J 313:775, 1996
45. Swillens S, Waelbroeck M, Champeil P: Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites? Trends Pharmacol Sci 16:151, 1995
46. Padro T, Emeis JJ, Steins M, Schmid KW, Kienast J: Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol 15:893, 1995
47. Felez J, Chanquia CJ, Levin EG, Miles LA, Plow EF: Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood 78:2318, 1991
48. Felez J, Chanquia CJ, Fabregas P, Plow EF, Miles LA: Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 82:2433, 1993
49. Cesarman GM, Guevara CA, Hajjar KA: An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269:21198, 1994
50. Eberhard DA, Brown MD, VandenBerg SR: Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol 145:640, 1994
51. 2+ binding protein (p67) in ventricular, skeletal, and smooth muscle cells. J Histochem Cytochem 40:1899, 1992
52. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T: Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem 269:3076, 1994
53. Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057, 1991
54. Hansen SH, Behrendt N, Danø K, Kristensen P: Localization of urokinase-type plasminogen activator receptor on U937 cells: Phorbol ester PMA induces heterogeneity. Exp Cell Res 187:255 1990
55. Ellis V, Lee SW, Dichek DA, Danø K: Characteristics of plasminogen activation by glycosylphosphatidylinositol- and transmembrane-anchored uPA. Fibrinolysis 8:1, 1994 (abstr, suppl 1)